INTECH Investment Management
PRME icon

INTECH Investment Management’s Prime Medicine PRME Stock Holding History

INTECH Investment Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$89.9K Sell
24,363
-6,175
-20% -$20.5K ﹤0.01% 1966
2026
Q1 		$106K Sell
30,538
-4,498
-13% -$17.1K ﹤0.01% 1884
2025
Q4 		$122K Buy
35,036
+11,808
+51% +$52.5K ﹤0.01% 2113
2025
Q3 		$129K Sell
23,228
-7,582
-25% -$30.8K ﹤0.01% 2199
2025
Q2 		$76.1K Sell
30,810
-24,136
-44% -$37.2K ﹤0.01% 2354
2025
Q1 		$109K Buy
54,946
+24,542
+81% +$62.6K ﹤0.01% 2293
2024
Q4 		$88.8K Buy
30,404
+16,302
+116% +$57.2K ﹤0.01% 2236
2024
Q3 		$54.6K Buy
+14,102
New +$65.3K ﹤0.01% 1975

Other funds holding PRME

Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Woodline Partners
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

INTECH Investment Management's PRME Position: Q2 2026 in Review

INTECH Investment Management reduced its Prime Medicine (PRME) stake by 20% in Q2 2026, selling an estimated $20.5K and leaving 24,363 shares worth $89.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1966.

INTECH Investment Management first reported a position in PRME in Q3 2024 and has held it in 8 quarters since. The position peaked at $129K in Q3 2025. 187 funds tracked by Wall St. Rank hold PRME as of Q2 2026.

  • INTECH Investment Management held 24,363 shares of Prime Medicine worth $89.9K as of Q2 2026.
  • INTECH Investment Management sold 6,175 Prime Medicine shares in Q2 2026, an estimated $20.5K.
  • Prime Medicine made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1966 holding.
  • INTECH Investment Management first reported a position in Prime Medicine in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Prime Medicine position peaked at $129K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Prime Medicine as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.